Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

Rallybio (RLYB) Net Margin (2024 - 2026)

Rallybio's Net Margin history spans 2 years, with the latest figure at 2636.04% for Q4 2025.

  • On a quarterly basis, Net Margin rose 2529554.0% to 2636.04% in Q4 2025 year-over-year; TTM through Dec 2025 was 944.52%, a 778755.0% increase, with the full-year FY2025 number at 944.52%, up 778755.0% from a year prior.
  • Net Margin hit 2636.04% in Q4 2025 for Rallybio, down from 7554.72% in the prior quarter.
  • Over the last five years, Net Margin for RLYB hit a ceiling of 7554.72% in Q3 2025 and a floor of 27931.58% in Q4 2024.